Comparative in vitro activity of nine antistaphylococcal agents against 275 recent isolates of Gram-positive cocci

被引:4
|
作者
Ravaoarinoro, M
Therrien, C
机构
[1] HOSP HOTEL DIEU,DEPT MICROBIOL & INFECT DIS,MONTREAL,PQ,CANADA
[2] UNIV MONTREAL,DEPT MICROBIOL & IMMUNOL,MONTREAL,PQ H3C 3J7,CANADA
关键词
in vitro activity; antimicrobial agents; Gram positive cocci; RESISTANT STAPHYLOCOCCUS-AUREUS; TEICHOMYCETICUS-NOV-SP; TEICOPLANIN; ENTEROCOCCI; VANCOMYCIN;
D O I
10.1016/S0924-8579(96)00317-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The aim of this study was to compare the in vitro activities of 9 antistaphylococcal agents including teicoplanin (TEI) against 275 non-repetitive clinical strains representing 15 species of staphylococci and 27 strains of Enterococcus (E.) faecalis, isolated from various specimens between 1991-1992 at a Canadian teaching hospital. The NCCLS agar dilution method was used (10(4) colony-forming units/spot). In terms of MIC(90), TEI and vancomycin (VAN) appeared to be the most potent antibiotics against all staphylococci tested (TEI: 2.0-4.0 mu g/ml; VAN: 1.0-2.0 mu g/ml; ciprofloxacin (CPF): 0.25-32 mu g/ml; cefazolin (CEF): 8.0-256 mu g/ml; methicillin (MET): 2.0->256 mu g/ml; imipenem (IMP): 1.0-32 mu g/ml; erythromycin (ERT): 16->256 mu g/ml; ampicillin (AMP): 16-128 mu g/ml; fusidic acid (FSA): 0.5-16 mu g/ml). Multiple resistant strains, including MET-resistant Staphylococcus (Staph.) aureus and Staph. epidermidis, were susceptible to TEI and VAN with respective MICs of 2-4 mu g/ml and 1-2 mu g/ml regardless of specimen type. Moreover, TEI was highly active against E. faecalis (MIC(90) for TEI and VAN: 0.5 and 4.0 mu g/ml, respectively).
引用
收藏
页码:167 / 170
页数:4
相关论文
共 50 条
  • [31] Activity of dalbavancin against gram-positive cocci isolated from skin and soft tissue infections in Poland
    Stefaniuk, Elzbieta M.
    Dudek, Monika
    Hryniewicz, Waleria
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2019, 95 (04)
  • [32] In vitro activity of telavancin compared with vancomycin and linezolid against Gram-positive organisms isolated from cancer patients
    Rolston, Kenneth V. I.
    Wang, Weiqun
    Nesher, Lior
    Coyle, Elizabeth
    Shelburne, Samuel
    Prince, Randall A.
    JOURNAL OF ANTIBIOTICS, 2014, 67 (07) : 505 - 509
  • [33] ANTIBACTERIAL ACTIVITY OF CITREAMICIN-ALPHA (LL-E-19085 ALPHA) AGAINST GRAM-POSITIVE COCCI
    QADRI, SMH
    SALDIN, H
    UENO, Y
    ALBALLAA, SR
    CHEMOTHERAPY, 1992, 38 (06) : 395 - 398
  • [34] Antibiotic-Like Behaviour of Polyoxometalates In vitro comparative study: seven polyoxotungstates - nine antibiotics against gram-positive and gram-negative bacteria
    Balici, Stefana
    Niculae, Mihaela
    Pall, Emoke
    Rusu, Mariana
    Rusu, Dan
    Matei, Horea
    REVISTA DE CHIMIE, 2016, 67 (03): : 485 - 490
  • [35] In vitro Antimicrobial Activity of Royleanone Derivatives Against Gram-Positive Bacterial Pathogens
    Rijo, Patricia
    Duarte, Aida
    Francisco, Ana Paula
    Semedo-Lemsaddek, Teresa
    Simoes, Maria Fatima
    PHYTOTHERAPY RESEARCH, 2014, 28 (01) : 76 - 81
  • [36] In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection
    C. Silvestri
    O. Cirioni
    D. Arzeni
    R. Ghiselli
    O. Simonetti
    F. Orlando
    G. Ganzetti
    S. Staffolani
    L. Brescini
    M. Provinciali
    A. Offidani
    M. Guerrieri
    A. Giacometti
    European Journal of Clinical Microbiology & Infectious Diseases, 2012, 31 : 1759 - 1764
  • [37] In vitro activity of oritavancin (LY333328), vancomycin, clindamycin, and metronidazole against Clostridium perfringens, Propionibacterium acnes, and anaerobic Gram-positive cocci
    Citron, DM
    Kwok, YY
    Appleman, MD
    ANAEROBE, 2005, 11 (1-2) : 93 - 95
  • [38] Activity of ceftaroline and comparator agents tested against contemporary Gram-positive and -negative (2011) isolates collected in Europe, Turkey, and Israel
    Castanheira, Mariana
    Jones, Ronald N.
    Sader, Helio S.
    JOURNAL OF CHEMOTHERAPY, 2014, 26 (04) : 202 - 210
  • [39] Antimicrobial activity of dalbavancin tested against Gram-positive clinical isolates from Latin American medical centres
    Gales, AC
    Sader, HS
    Jones, RN
    CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (02) : 95 - 100
  • [40] Antimicrobial activity of oritavancin and comparator agents when tested against Gram-positive bacterial isolates causing infections in cancer patients (2014-16)
    Pfaller, Michael A.
    Sader, Helio S.
    Castanheira, Mariana
    Flamm, Robert K.
    Mendes, Rodrigo E.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (04) : 916 - 922